Neutralized HIV Antibodies Being Used To Develop Vaccine Cure
Researchers have long been looking for a possible cure for HIV. Now it seems that there might be a breakthrough coming along as neutralized HIV antibodies are being developed to make for a possible vaccine for HIV. The nature of HIV makes it hard to find a cure for it.
HIV has various strains which have mutated over time. Finding a common cure for it is hard as the virus mutates at a rapid pace. However researchers might have found what they've been looking for, a vaccine that relies on broadly neutralizing antibodies or bnAbs.
Researchers from Scripps Research Institute, led by Ian Wilson, Dennis Burton and William Schief have been working on bnAbs for a possible solution to HIV. They are building on research first made by Joseph Jardine, Devin Sok, Jean-Philippe Julien and Brian Briney of Scripps Research Institute.
Getting bnAbs from HIV infected individuals is not easy, as these antibodies are rare. That is because HIV mutates rapidly which makes harvesting them hard, as the Medical Express says in its report. The challenge now is to engineer or discover bnAbs that have fewer rare features. These are the bnAbs that are needed in order to make a vaccine effective in fighting HIV.
Such bnAbs attack the core features of HIV. There are people who have developed such antibodies in their system that they could cope from the disease without the need for any medication. However, such antibodies are also generated years after HIV has progressed, as The San Diego Tribune notes. By then the virus has been much established that it would be hard to neutralize it.
Getting these antibodies and researching on how they work on HIV affected people are now the main focus of Wilson and his colleagues. Howard Liebman, M.D. is a professor of medicine at Keck Medicine at the University of California and has remarked on the research being done on bnAbs.
"What they have to do is develop these immunogens and see what happens when they give them to normal controls," Liebman remarked on the research. From there then those who have developed resistance to HIV and get the antibodies from them in order to produce vaccine from it.
However the work is far from over, as he also pointed out that there is still much clinical and real world trials to be done before the vaccine can truly be called as effective. One of the researchers, William Schief has also said that more classes of antibodies would be needed for the research.
bnAbs is a first step towards the fight against HIV, but it would be a long struggle against it. It could lead to a possible breakthrough though and a vaccine that would ultimately halt HIV and its spread to other people.
iTechPost also reports that scientists hope to make mice transparent for research.
HIV, The Next Target Of Trump Administration
As continuous efforts to eradicate HIV are taking place, why does the Trump administration wanted to halt the treatment that has been started by the previous government? What’s the truth behind claims that if the current US President would push this through, it will kill thousands? Find out what authorities have to say
How Do We Reduce HIV Risk? Here Are Experts' Tips
With the continuous efforts to eradicate one of the world's long dreaded disease, can we really do certain precautionary measures to prevent the risk of HIV? What are the necessary steps to prevent transmission of the disease? Find out what experts have to say
HIV Vaccine Cures Five Patients For Seven Months
New AIDS vaccine developed in Spain have reportedly cured 5 patients, helping them remain virus-free for seven months after taking the treatment. In the study, the treatment allowed the patients to stop taking regular antiretroviral (ARV) drugs to suppress HIV symptoms.
Nanotechnology For HIV: New Technique Shows Promising Results In HIV Treatment
With continuous efforts to eradicate HIV being one of the world's long dreaded disease, how essential does nanotechnology's role can be? What's the truth behind claims that this new technique offers a new hope as it has induced positive results in HIV treatment? Could it be the answer to the disease? Find out what experts have to say
PrEP For HIV: Raising Awareness; Could It Be The Cure For The Disease?
Considering that HIV has been and is still currently is one of the world’s most dreaded diseases, how essential is the use of PrEP? Could it possibly hold the key for cure that a lot of people have been waiting for? What’s the truth behind claims these claims? Find out what health professionals have to say
HIV Update: The 'HIV Conserv’ Vaccine And Its Promising Results
Considering the continuous efforts to eradicate the global health problem brought by HIV, what's the truth behind claims of a researcher about the so-called 'kick and kill' strategy by being a potential key for the long dreaded disease? How effective is this trial and what are the chances of being cured from the disease? Find out what experts have to say
MORE IN ITECHPOST
Mobile Phone App Designed to Boost Physical Activity in Women Shows Promise in Trial
Activity trackers and mobile phone apps are all the rage, but do they really help users increase and maintain physical activity? A new study has found that one mobile phone app designed for inactive women did help when combined with an activity tracker and personal counseling.
AI and High-Performance Computing Extend Evolution to Superconductors
Materials by design: Argonne researchers use genetic algorithms for better superconductors.
Owners of thoroughbred stallions carefully breed prizewinning horses over generations to eke out fractions of a second in million-dollar races. Materials scientists have taken a page from that playbook, turning to the power of evolution and artificial selection to develop superconductors that can transmit electric current as efficiently as possible.